SCHEMBL6471735

SCHEMBL6471735

C[C@@H]1CN(C(=O)c2ccccn2)CCN1C(=O)C(=O)c1c[nH]c2c(OC(N)=O)ccc(F)c12

nearest known ligand 0.53

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 4/20 0.53
CYP2C19 P33261 5/20 0.51
CYP2C9 P11712 4/20 0.51
CYP3A4 P08684 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.42
GHSR Q92847 5/20 0.39
RBP4 P02753 3/20 0.38
CFTR P13569 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6445636 0.89 CYP2C19 (0.51) CYP2D6CYP2C19CYP2C9CYP3A4SMN1; SMN2
SCHEMBL7073321 0.89 CYP2C19 (0.51) CYP2D6CYP2C19CYP2C9CYP3A4SMN1; SMN2
SCHEMBL6441266 0.89 CYP2D6 (0.60) CYP2D6CYP2C19CYP2C9CYP3A4GHSR
SCHEMBL6473347 0.88 CYP2C9 (0.47) CYP2D6CYP2C19CYP2C9CYP3A4SMN1; SMN2
SCHEMBL6441429 0.86 CYP2C19 (0.49) CYP2D6CYP2C19CYP2C9CYP3A4SMN1; SMN2
SCHEMBL6441534 0.84 CYP2C19 (0.51) CYP2D6CYP2C19CYP2C9CYP3A4SMN1; SMN2
SCHEMBL6441531 0.84 CYP2C19 (0.51) CYP2D6CYP2C19CYP2C9CYP3A4SMN1; SMN2
SCHEMBL9942597 0.84 CYP2C19 (0.51) CYP2D6CYP2C19CYP2C9CYP3A4SMN1; SMN2
SCHEMBL1763119 0.83 CYP2C19 (0.51) CYP2D6CYP2C19CYP2C9CYP3A4SMN1; SMN2
SCHEMBL2633280 0.83 CYP2C19 (0.51) CYP2D6CYP2C19CYP2C9CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299382-B1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED INDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2005-09-21 EP claimed